Phaseline

Targets › ROTV

ROTV: drug programs, companies and trials

1 program from 1 company in 2 trials: 2 Phase 2; Infectious disease.

Open in Phaseline: the race on ROTV, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
MAXVAX Biotechnology Limited Liability CompanyRecombinant Trivalent Subunit Rotavirus Vaccine (Mid dose)
Recombinant rotavirus subunit vaccine with P types; adjuvanted with aluminum hydroxide
ROTVPhase 2Rotavirus Infections–

Conditions

Rotavirus Infections (2)

Modalities

other (1)

Companies

MAXVAX Biotechnology Limited Liability Company (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.